A closer look at the evidence behind devices deemed "breakthrough" by FDA.

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

For older adults, the longer someone stays in the emergency department, the worse the experience can get for them, with ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of ...

RFK Jr. wants to change federal programs that helps people injured by vaccines, though he may need Congress to do so.

A scientific message will not resonate unless viewers have clear reason to care about the issue and, more importantly, to ...

A controversial collaboration between Duke and cord blood banker Cryo-Cell could be a worrisome sign of things to come in ...

Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month.

HHS will renew funding to states for cancer prevention and tracking efforts, alleviating anxieties among local officials ...

The Affordable Care Act survived yet another trip to the Supreme Court. The justices quibbled over just how powerful the ...

The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.